Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
An open-access 2020 review asking why chronic lung allograft dysfunction presents as two distinct forms, BOS and RAS.
As of . Primary source: Publisher record via DOI.
Summary
Review in Annals of Translational Medicine, 2020, volume 8, page 418, by Masaaki Sato. Its abstract describes BOS as a disease in which small airways are affected by chronic inflammation and obliterative fibrosis while peripheral lung tissue stays relatively intact, and RAS as a form involving multiple tissue compartments of the lung.
Details
- doi
- 10.21037/atm.2020.02.159
- pmid
- 32355862
- authors
- Sato M
- journal
- Annals of Translational Medicine
- year
- 2020
- volume
- 8
- pages
- 418
Sources and links
Related
Links from this record
- describes: Bronchiolitis obliterans syndrome (BOS)
- describes: Restrictive allograft syndrome (RAS)
Linked from (derived)
- summarised in: Bronchiolitis obliterans syndrome (BOS)
- summarised in: Restrictive allograft syndrome (RAS)
Known gaps in this record
- funding statement
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.